4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001079973-26-000008
Chief Financial Officer sold 247 shares at $3.56 ($879)
From the SEC's structured data for this filing
Trades in this filing
Carter Robert Ross · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-02 | Sale : show line 1 in the form | −247 | $3.56 | $879 | 235,122 | D |
| Open-market sales · 247 sh · avg $3.56 · $879 | ||||||
Loading xslF345X05/ownership.xml…